SCHEMBL21362528

SCHEMBL21362528

COc1cc(C(=O)c2ccc(C)cc2Br)c(C)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2C9 P11712 1/20 0.39
MAPT P10636 4/20 0.37
GAA P10253 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158043 0.87 RAB9A (0.41) LCKFYNALDH1A1RAB9AHTT
SCHEMBL21362819 0.85 ACHE (0.40) LCKFYNALDH1A1RAB9AHTT
SCHEMBL20157484 0.84 ALDH1A1 (0.48) ALDH1A1RAB9AHTTLMNAMAPK1
SCHEMBL20158084 0.84 HTT (0.54) ALDH1A1RAB9AHTTLMNAMAPK1
SCHEMBL20158021 0.81 LCK (0.46) LCKFYNALDH1A1RAB9AHTT
SCHEMBL20158157 0.81 KMT2A (0.41) LCKFYNALDH1A1RAB9AHTT
Sulfamide SCHEMBL21352056 0.79 ALDH1A1 (0.43) ALDH1A1HTTLMNAMAPK1POLB
SCHEMBL29053399 0.78 LCK (0.56) LCKFYNALDH1A1RAB9AHTT
SCHEMBL20157483 0.78 ALDH1A1 (0.50) LCKFYNALDH1A1HTTMAPK1
SCHEMBL20157893 0.78 NPC1 (0.41) RAB9AHTTMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed